Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gábor Szántó
Observed name:
Gabor Szanto
Institution:
Gedeon Richter (Hungary)
Observed institutions:
Gedeon Richter (Hungary),
Budapest University of Technology and Economics,
Hungarian Academy of Sciences
ORCID:
0000-0003-2865-2804
Observed ORCID:
0000-0003-2865-2804
OpenAlex ID:
A5061681972
An expedient total synthesis of ent-(−)-7-deoxy-trans-dihydronarciclasine
2009
·
Gábor Szántó
, László Hegedűs
, et al.
·
Tetrahedron
·
36
Stereoselective total synthesis of (±)-7-deoxy-trans-dihydronarciclasine, a potent antineoplastic phenanthridone alkaloid
2009
·
Gábor Szántó
, László Hegedűs
, et al.
·
Tetrahedron Letters
·
22
Highly enantioselective organocatalytic conjugate addition of nitromethane to benzylidene acetones
2008
·
Gábor Szántó
, Petra Bombicz
, et al.
·
Chirality
·
12
Stereochemistry of 1,3‐dipolar‐cycloaddition of 3,4‐dihydroisoquinoline‐ and 3,4‐dihydro‐carboline‐N‐methoxycarbonyl‐ and N‐phenacyl‐methylides with maleic and fumaric nitrile
2007
·
István Kádas
, Gábor Szántó
, et al.
·
Journal of Heterocyclic Chemistry
·
11
Discovery of New Heterocyclic Ring Systems as Novel and Potent V1A Receptor Antagonists
2020
·
Ferenc Baska
, Gábor Szántó
, et al.
·
ACS Chemical Neuroscience
·
8
New V1a receptor antagonist. Part 2. Identification and optimization of triazolobenzazepines
2020
·
Éva Bozó
, Ferenc Baska
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
6
New P2X3 receptor antagonists. Part 2: Identification and SAR of quinazolinones
2016
·
Gábor Szántó
, Attila Makó
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
5
New P2X3 receptor antagonists. Part 1: Discovery and optimization of tricyclic compounds
2016
·
Gábor Szántó
, Attila Makó
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
5
Hydrogenation of (±)-trans-2-arylnitrocyclohexane derivatives over palladium
2009
·
Gábor Szántó
, István Kádas
, et al.
·
Reaction Kinetics Mechanisms and Catalysis
·
5
Discovery and Characterization of RGH-122, a Potent, Selective, and Orally Bioavailable V1a Receptor Antagonist
2024
·
Ferenc Baska
, Éva Bozó
, et al.
·
Journal of Medicinal Chemistry
·
4
Novel-Type GABAB PAMs: Structure–Activity Relationship in Light of the Protein Structure
2024
·
Balázs Krámos
, Zsuzsa Hadady
, et al.
·
ACS Medicinal Chemistry Letters
·
3
PDF
New V1a receptor antagonist. Part 1. Synthesis and SAR development of urea derivatives
2020
·
Gábor Szántó
, Attila Makó
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
2
Development of dual V1a/V2 antagonists containing triazolobenzazepine scaffold
2024
·
Gábor Varró
, Éva Bozó
, et al.
·
European Journal of Medicinal Chemistry
·
1
ChemInform Abstract: Stereochemistry of 1,3‐Dipolar‐cycloaddition of 3,4‐Dihydroisoquinoline‐ and 3,4‐Dihydro‐carboline‐N‐methoxycarbonyl‐ and N‐Phenacyl‐methylides with Maleic and Fumaric Nitrile.
2008
·
Istvan Kadas
, Gabor Szanto
, et al.
·
ChemInform
Show more works
View as search
Works count:
14
Citation count:
120
H-index:
6
I10-index:
4
Year
Topic
Type